WATERTOWN – Selecta Biosciences (NASDAQ:SELB), a biotech company based in Watertown, Massachusetts, announced today its reverse merger with Cartesian Therapeutics. The merger culminates in a new entity with a robust financial position, boasting over $110 million in cash reserves. This includes a significant $60 million from a private investment round…Read More
Selecta Biosciences merges with Cartesian Therapeutics in allstock deal By Investingcom
